Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Change in Account Payables (2016 - 2025)

Traws Pharma's Change in Account Payables history spans 14 years, with the latest figure at $2.5 million for Q4 2025.

  • Quarterly results put Change in Account Payables at $2.5 million for Q4 2025, up 211.35% from a year ago — trailing twelve months through Dec 2025 was -$612000.0 (down 194.74% YoY), and the annual figure for FY2025 was -$612000.0, down 194.74%.
  • Change in Account Payables for Q4 2025 was $2.5 million at Traws Pharma, up from $524000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.5 million in Q4 2025 to a low of -$3.0 million in Q2 2025.
  • The 5-year median for Change in Account Payables is $137500.0 (2022), against an average of $41000.0.
  • The sharpest move saw Change in Account Payables crashed 860.23% in 2021, then soared 415.42% in 2022.
  • Year by year, Change in Account Payables stood at -$1.3 million in 2021, then skyrocketed by 107.73% to $100000.0 in 2022, then crashed by 629.0% to -$529000.0 in 2023, then soared by 249.91% to $793000.0 in 2024, then soared by 211.35% to $2.5 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $2.5 million, $524000.0, and -$3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.